TY - JOUR
T1 - Insights into the biology of primary central nervous system lymphoma.
AU - Mrugala, Maciej M.
AU - Rubenstein, James L.
AU - Ponzoni, Maurilio
AU - Batchelor, Tracy T.
PY - 2009/1
Y1 - 2009/1
N2 - Primary central nervous system lymphoma (PCNSL) is a rare variant of non-Hodgkin lymphoma that is confined to the central nervous system. Biologic studies of PCNSL are challenging to conduct because the disease is rare and available tissue material is sparse. However, in recent years there has been progress in the understanding of PCNSL biology, largely as the result of multicenter studies using modern molecular techniques. Recent studies may improve insight into the pathogenesis of PCNSL and increase the chances of identifying prognostic factors and novel therapeutic targets. This review discusses recent advances in PCNSL biology, including immunologic and genetic risk factors, and focuses on the molecular alterations important in central nervous system lymphomagenesis.
AB - Primary central nervous system lymphoma (PCNSL) is a rare variant of non-Hodgkin lymphoma that is confined to the central nervous system. Biologic studies of PCNSL are challenging to conduct because the disease is rare and available tissue material is sparse. However, in recent years there has been progress in the understanding of PCNSL biology, largely as the result of multicenter studies using modern molecular techniques. Recent studies may improve insight into the pathogenesis of PCNSL and increase the chances of identifying prognostic factors and novel therapeutic targets. This review discusses recent advances in PCNSL biology, including immunologic and genetic risk factors, and focuses on the molecular alterations important in central nervous system lymphomagenesis.
UR - http://www.scopus.com/inward/record.url?scp=63149137763&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=63149137763&partnerID=8YFLogxK
U2 - 10.1007/s11912-009-0012-8
DO - 10.1007/s11912-009-0012-8
M3 - Review article
C2 - 19080745
AN - SCOPUS:63149137763
SN - 1523-3790
VL - 11
SP - 73
EP - 80
JO - Current oncology reports
JF - Current oncology reports
IS - 1
ER -